PATENT CLAIM ANALYSIS

Application Number: 16032314
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Described herein, are microneedle devices comprising a recombinant alphavirus replicon encoding an exogenous polypeptide, wherein the recombinant alphavirus replicon is coated onto or embedded into a plurality of microneedles. Also described herein are methods of preparing a microneedle device comprising a recombinant alphavirus replicon encoding an exogenous polypeptide. Also disclosed herein are methods of inducing an immune response in an individual comprising contacting the individual with a microneedle device comprising a recombinant alphavirus replicon encoding an exogenous polypeptide.

Claim (Index 100):
The microneedle device of  claim 98 , wherein the polypeptide is present in an amount effective to induce an immune response in an individual in need thereof to the polypeptide.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 95.0
- Lexical Diversity: 2.075
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14463831', '15317593', '12748265', '14109358', '12788103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7264421412081916
- 35 USC 102 Novelty (BERT): 0.5727071723725694
- Combined Prediction Score: 0.7110686443246295
- Mean Citation Score: 311.749572
- Max Citation Score: 381.99078
- Similarity Product: 258.77853873177054

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test